Sirona Biochem Corp. (CVE:SBM – Get Free Report) dropped 18.8% on Tuesday . The company traded as low as C$0.07 and last traded at C$0.07. Approximately 112,944 shares traded hands during mid-day trading, an increase of 44% from the average daily volume of 78,445 shares. The stock had previously closed at C$0.08.
Sirona Biochem Price Performance
The company has a debt-to-equity ratio of 219.21, a current ratio of 0.34 and a quick ratio of 2.41. The company’s 50 day moving average price is C$0.07 and its 200 day moving average price is C$0.06. The firm has a market capitalization of C$16.69 million, a P/E ratio of -6.50 and a beta of -0.03.
About Sirona Biochem
Sirona Biochem Corp., a cosmetic ingredient and drug discovery company, develops and sells cosmetic and pharmaceutical active ingredients in Canada and France. Its programs include cosmetic skin lightener and diabetes drug; and other projects comprise the development of an anti-aging/cell protection library, novel anti-wrinkle compound, and anti-viral program.
Read More
- Five stocks we like better than Sirona Biochem
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Where to Find Earnings Call Transcripts
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- Top Biotech Stocks: Exploring Innovation Opportunities
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for Sirona Biochem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sirona Biochem and related companies with MarketBeat.com's FREE daily email newsletter.
